Innovation

Restoration Of Visually Evoked Center-surround Antagonism Using Photosensitive Opsins

University of California System: University of California, Berkeley
posted on 07/12/2010

Retinal degeneration culminates in mild to severe vision loss resulting from mutations in 196 different genes that cause the death of light sensitive photoreceptor cells, but leave the non-photosensitive inner retinal n eurons intact. Center-Surround Antagonism is a functional property of normal vision that allows for high acuity, contrast sensitivity and useful spatial vision.   Restoring this property to a blind retina is crucial for re-establishing functional vision following rod and cone loss due to injury or retinal degeneration. Scientists at UC Berkeley have developed a method to directly insert light sensitive proteins (Photosensitive Opsins) into non-photosensitive retinal neurons, allowing those neurons to act as photoreceptors and restore center-surround antagonism.

Suggested Uses

  • This method is a potential future therapy for restoring sight to the blind.

Advantages


  • Gene therapy targeting non-photosensitive retinal neurons
  • Gene therapy in the eye has been successful in animal trials
  • Restores enhanced contrast and edge sensitivity
  • Decreases “blur”
  • Possible therapy for those that have suffered substantial photoreceptor loss


Innovation Details
 

File Number: 18090 

Disease: Ophthalmology and Optometry


IP Protection

Patent Number(s): 2011/0224145
Copyright: ©2010-2011, The Regents of the University of California

License Online

This innovation currently is not available for online licensing. Please contact Javed Afzal at University of California System: University of California, Berkeley for more information.

Request more info via email request more info
People

Case Manager:

Javed Afzal Javed Afzal

Innovations (37)


Download Technology Brief (PDF)


Followed By

Follow this innovation



No one is following this innovation.

Organization
Profile
Related Tags

Find more innovations


February 11, 2009

7,868 members 17,196 innovations 152 organizations

Browse

Scott Steele, coordinator of the CTSA-IP initiative and director of research alliances at the University of Rochester

"With more than 3,700 innovations from CTSA member institutions already on the iBridge Network, we're garnering worldwide exposure for the breakthroughs our researchers are accomplishing while moving toward our goal of increasing human health through clinical and translational research."  read more...